Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

Aug 31, 2022

London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty...

Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India

May 03, 2021

Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the...

Air Quality in 'severe' category in Delhi NCR; children upto age 16 more vulnerable to pollution, says expert

Nov 03, 2022

Diminishing air quality in the national capital is affecting children up to 16 years of age more as compared to the adults. The pediatric...

Dr Batra's Healthcare launches scientific homeopathy treatments for food, skin and respiratory allergies

Sep 03, 2021

Mumbai (Maharashtra), [India], September 3 (ANI/PRNewswire): According to the World Health Organization, the estimated number of people with asthma, which is linked to...

Glenmark's Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Apr 26, 2021

Mumbai (Maharashtra) [India], April 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing...

Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™ Nasal Spray"

Jan 14, 2022

Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A....